Recombinant Proteins Market, By Type (Antibodies, Virus Antigens, Enzymes, Hormones, Immune Checkpoint Proteins, Cytokines & Growth Factors, and Recombinant Regulatory Protein), By Application, By End-User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5221
|
Published Date
May 2026
|
Pages
353
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Recombinant Proteins Market size was valued at US$ 3,309.72 Million in 2025, expanding at a CAGR of 10.03% from 2026 to 2033.
Recombinant proteins are laboratory-produced proteins created by inserting a specific gene into host cells such as bacteria, yeast, or mammalian cells, enabling them to produce a target protein in a controlled and precise manner. Instead of being extracted directly from human or animal sources, cells are engineered to function as biological “factories” that synthesize important therapeutic and research-grade proteins. These proteins are widely used in medicines, vaccines, and biomedical research due to their high purity, consistency, and improved safety compared to naturally derived protein sources.
The development and adoption of recombinant protein technologies are driven by growing healthcare demands and strong institutional support across global health systems. Regulatory agencies such as the U.S. Food and Drug Administration have approved more than 100 biologic medicines derived from recombinant technologies, reflecting their established role in modern therapeutics. The National Institutes of Health allocates substantial annual funding—over USD 45 billion—for biomedical research that supports innovations in protein engineering and biologics development. In addition, India’s Ministry of Health and Family Welfare supports vaccine development and biologics programs through national immunization and biotechnology initiatives, further strengthening the global ecosystem for recombinant protein-based advancements.
Recombinant Proteins Market- Market Dynamics
Increasing Government Support for Biotechnology Research and Manufacturing
Support from public institutions plays a crucial role in shaping the growth of recombinant protein development by influencing research direction and accelerating innovation. Governments typically provide funding programs, research grants, and policy frameworks that enable scientists and biotechnology companies to advance new discoveries and translate them into practical applications. For example, UK Research and Innovation has allocated significant funding toward scientific research programs, including biologics and advanced therapeutic development. In Asia, the Department of Biotechnology continues to support vaccine development and recombinant technology initiatives through national missions and research funding programs. Similarly, Japan’s Ministry of Economy, Trade and Industry promotes industrial biotechnology initiatives aimed at improving production efficiency and strengthening biomanufacturing capabilities.
From an industry perspective, companies are responding to this supportive policy environment by expanding their capabilities and infrastructure. Lonza Group has expanded its biologics manufacturing facilities, while GenScript Biotech has strengthened its high-throughput protein production platforms. Collectively, these developments highlight how government support is accelerating both innovation and commercial scalability in recombinant protein technologies.
Recombinant Proteins Market- Segmentation Analysis:
The Global Recombinant Proteins Market is segmented on the basis of Type, Application, End-User, and Region.
As per type classification, the recombinant proteins market is segmented into seven categories: antibodies, viral antigens, enzymes, hormones, immune checkpoint proteins, cytokines & growth factors, and recombinant regulatory proteins. Among these, antibodies represent a dominant segment due to their widespread application in targeted therapies, particularly in oncology and autoimmune disease treatment. They are highly valued because they can be engineered to specifically recognize and bind disease-related biomarkers, enabling more precise treatment approaches with reduced side effects. From a business perspective, Roche has developed multiple recombinant monoclonal antibody therapies, with its oncology portfolio contributing over CHF 20 billion in combined therapeutic product sales, as reported in its annual disclosures. Similarly, Amgen continues to advance its antibody-based biologics pipeline, with several approved recombinant antibody products contributing significantly to its biologics revenue stream.
Based on end-user segmentation, pharmaceutical and biotechnology companies represent a key and continuously active segment in the market, driven by their role in drug discovery, clinical development, and large-scale biologics production. These organizations consistently invest in protein engineering to develop therapies for chronic and complex diseases, making them central to ongoing innovation and manufacturing demand. For instance, Novo Nordisk utilizes recombinant protein technology extensively in its insulin and hormone therapy portfolio, which forms a core part of its treatment offerings. Likewise, Sanofi continues to expand its recombinant biologics pipeline across diabetes and immunology segments, supported by its growing manufacturing and R&D capabilities.
Recombinant Proteins Market- Geographical Insights
A closer examination of regional trends indicates that the recombinant proteins market is shaped by public health initiatives, research funding frameworks, and biotechnology infrastructure across key regions such as North America, Europe, and Asia-Pacific. Among these, North America is expected to contribute significantly due to its well-established regulatory environment and strong scientific research base.
In the United States, the U.S. Food and Drug Administration continues to support biologic therapies, with more than 100 recombinant protein-based products approved for clinical use. The National Institutes of Health invests over USD 45 billion annually in biomedical research, strengthening innovation pipelines in protein engineering and biologics development. Additionally, the Centers for Disease Control and Prevention reports that 6 in 10 adults in the U.S. are living with chronic diseases, highlighting sustained demand for biologic-based treatments. In Canada, the Public Health Agency of Canada supports vaccine development and biologics programs through coordinated public health and research initiatives. Collectively, these factors reflect a stable environment where regulatory support, sustained research funding, and growing healthcare needs continue to drive the adoption of recombinant protein technologies across North America.
UK Recombinant Proteins Market- Country Insights
The United Kingdom represents a well-established environment for recombinant protein development, supported by strong public funding and a highly active life sciences ecosystem. Academic institutions, public research organizations, and healthcare bodies work in close collaboration, enabling scientific discoveries to progress steadily from laboratory research into clinical and commercial applications.
Government commitment is reflected in initiatives such as the £520 million Life Sciences Innovative Manufacturing Fund, which supports domestic production capacity for advanced biologics and healthcare technologies. In addition, the National Health Service continues to enable widespread adoption of biologic therapies, reflecting sustained demand for protein-based treatments across the healthcare system. Public research efforts are further strengthened by UK Research and Innovation, which invests billions annually in scientific research and innovation programs. These initiatives are supported by national strategies aimed at accelerating access to biologic therapies and improving the translation of research outcomes into practical healthcare applications across the United Kingdom.
Recombinant Proteins Market- Competitive Landscape:
Due to the increasing reliance on biologics and precision therapies, the recombinant proteins market is shaped by a combination of biotechnology companies and specialized life science providers, creating an ecosystem where innovation and production capabilities work in tandem. Companies such as Amgen, GenScript Biotech, Lonza Group, Bio-Rad Laboratories, and Sartorius AG operate through direct sales channels, digital platforms, contract manufacturing services, and research collaborations to serve pharmaceutical companies and research laboratories.
These players differentiate themselves based on protein quality, scalability, technical expertise, and production turnaround times. Common strategic approaches include expanding manufacturing capacity, strengthening global distribution networks, and investing in advanced protein expression systems. For example, Lonza Group has expanded its biologics manufacturing capabilities to meet growing global demand, while GenScript Biotech has introduced high-throughput protein production services to accelerate research and development workflows. These developments highlight a continued shift toward efficiency, collaboration, and technology-driven growth in the sector.
Recent Developments
- In January 2026, Thermo Fisher Scientific introduced an expanded range of recombinant protein expression systems designed to improve yield and purity in biopharmaceutical manufacturing. The initiative aims to enhance production efficiency, support scalable biologics development, and accelerate manufacturing timelines globally.
- In November 2025, Merck KGaA entered a strategic collaboration with BioNTech to strengthen recombinant protein production workflows for next-generation therapeutics, particularly in oncology and immunotherapy applications, improving efficiency and advancing advanced therapeutic development.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RECOMBINANT PROTEINS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Bio-Techne Corporation
- Bio-Rad Laboratories Inc.
- Lonza Group AG
- Sartorius AG
- Abcam plc
- GenScript Biotech Corporation
- Sino Biological Inc.
- Abnova Corporation
- R&D Systems (Bio-Techne)
- Eli Lilly and Company
- Amgen Inc.
- Novo Nordisk A/S
- Sanofi S.A.
- F. Hoffmann-La Roche Ltd.
- Pfizer Inc.
- Novartis AG
- GlaxoSmithKline plc
- Boehringer Ingelheim International GmbH
- Ajinomoto Co., Inc.
- FUJIFILM Holdings Corporation
- Danaher Corporation
- PerkinElmer Inc. (Revvity)
- Others
GLOBAL RECOMBINANT PROTEINS MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Antibodies
- Virus Antigens
- Enzymes
- Hormones
- Immune Checkpoint Proteins
- Cytokines & Growth Factors
- Recombinant Regulatory Protein
- Others
GLOBAL RECOMBINANT PROTEINS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Drug Discovery & Development
- Biologics
- Cell & Gene Therapy
- Vaccines
- Biotechnology Research
- Biopharmaceutical Production
- Academic Research Studies
- Others
GLOBAL RECOMBINANT PROTEINS MARKET, BY END-USER- MARKET ANALYSIS, 2020 - 2033
- Academic Research Institutes
- Contract Research Organizations (CROs)
- Pharmaceutical & Biotechnology Companies
- Others
GLOBAL RECOMBINANT PROTEINS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Recombinant Proteins Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Recombinant Proteins Market Snippet by Type
2.1.2. Recombinant Proteins Market Snippet by Application
2.1.3. Recombinant Proteins Market Snippet by End-User
2.1.4. Recombinant Proteins Market Snippet by Country
2.1.5. Recombinant Proteins Market Snippet by Region
2.2. Competitive Insights
3. Recombinant Proteins Key Market Trends
3.1. Recombinant Proteins Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Recombinant Proteins Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Recombinant Proteins Market Opportunities
3.4. Recombinant Proteins Market Future Trends
4. Recombinant Proteins Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Recombinant Proteins Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Recombinant Proteins Market Landscape
6.1. Recombinant Proteins Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Recombinant Proteins Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
7.1.2. Antibodies
7.1.3. Virus Antigens
7.1.4. Enzymes
7.1.5. Hormones
7.1.6. Immune Checkpoint Proteins
7.1.7. Cytokines & Growth Factors
7.1.8. Recombinant Regulatory Protein
7.1.9. Others
8. Recombinant Proteins Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Drug Discovery & Development
8.1.2.1. Biologics
8.1.2.2. Cell & Gene Therapy
8.1.2.3. Vaccines
8.1.3. Biotechnology Research
8.1.4. Biopharmaceutical Production
8.1.5. Academic Research Studies
8.1.6. Others
9. Recombinant Proteins Market – By End-User
9.1. Overview
9.1.1. Segment Share Analysis, By End-User, 2025 & 2033 (%)
9.1.2. Academic Research Institutes
9.1.3. Contract Research Organizations (CROs)
9.1.4. Pharmaceutical & Biotechnology Companies
9.1.5. Others
10. Recombinant Proteins Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2. North America
10.2.1. Overview
10.2.2. Recombinant Proteins Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Recombinant Proteins Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.3.16. Denmark
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.16.3. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.16.5. Denmark Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.3.17. Rest of Europe
10.3.17.1. Overview
10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.17.5. Rest of the Europe Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Recombinant Proteins Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.4.15. Taiwan
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.15.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.15.5. Taiwan Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.4.16. Vietnam
10.4.16.1. Overview
10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.16.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.16.5. Vietnam Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.4.17. Rest of APAC
10.4.17.1. Overview
10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.17.5. Rest of APAC Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Recombinant Proteins Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Recombinant Proteins Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.6.13. Iran
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.13.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.13.5. Iran Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.6.14. Qatar
10.6.14.1. Overview
10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.14.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.14.5. Qatar Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
10.6.15. Rest of MEA
10.6.15.1. Overview
10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.15.5. Rest of MEA Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- Recombinant Proteins Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Thermo Fisher Scientific Inc.
11.2.2. Merck KGaA
11.2.3. Bio-Techne Corporation
11.2.4. Bio-Rad Laboratories Inc.
11.2.5. Lonza Group AG
11.2.6. Sartorius AG
11.2.7. Abcam plc
11.2.8. GenScript Biotech Corporation
11.2.9. Sino Biological Inc.
11.2.10. Abnova Corporation
11.2.11. R&D Systems (Bio-Techne)
11.2.12. Eli Lilly and Company
11.2.13. Amgen Inc.
11.2.14. Novo Nordisk A/S
11.2.15. Sanofi S.A.
11.2.16. F. Hoffmann-La Roche Ltd.
11.2.17. Pfizer Inc.
11.2.18. Novartis AG
11.2.19. GlaxoSmithKline plc
11.2.20. Boehringer Ingelheim International GmbH
11.2.21. Ajinomoto Co., Inc.
11.2.22. FUJIFILM Holdings Corporation
11.2.23. Danaher Corporation
11.2.24. PerkinElmer Inc. (Revvity)
11.2.25. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RECOMBINANT PROTEINS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Bio-Techne Corporation
- Bio-Rad Laboratories Inc.
- Lonza Group AG
- Sartorius AG
- Abcam plc
- GenScript Biotech Corporation
- Sino Biological Inc.
- Abnova Corporation
- R&D Systems (Bio-Techne)
- Eli Lilly and Company
- Amgen Inc.
- Novo Nordisk A/S
- Sanofi S.A.
- F. Hoffmann-La Roche Ltd.
- Pfizer Inc.
- Novartis AG
- GlaxoSmithKline plc
- Boehringer Ingelheim International GmbH
- Ajinomoto Co., Inc.
- FUJIFILM Holdings Corporation
- Danaher Corporation
- PerkinElmer Inc. (Revvity)
- Others
GLOBAL RECOMBINANT PROTEINS MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Antibodies
- Virus Antigens
- Enzymes
- Hormones
- Immune Checkpoint Proteins
- Cytokines & Growth Factors
- Recombinant Regulatory Protein
- Others
GLOBAL RECOMBINANT PROTEINS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Drug Discovery & Development
- Biologics
- Cell & Gene Therapy
- Vaccines
- Biotechnology Research
- Biopharmaceutical Production
- Academic Research Studies
- Others
GLOBAL RECOMBINANT PROTEINS MARKET, BY END-USER- MARKET ANALYSIS, 2020 - 2033
- Academic Research Institutes
- Contract Research Organizations (CROs)
- Pharmaceutical & Biotechnology Companies
- Others
GLOBAL RECOMBINANT PROTEINS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
